2125 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2024
JOURNALProceedings of the National Academy of Sciences of the United States of America
PREMIER AUTEURLi C
TITRETargeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunity.
ANNÉE2024
JOURNALJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
PREMIER AUTEURLepage V
TITREA 14-year retrospective of HER2  + metastatic breast cancer treatment at one comprehensive cancer center: Impact of the trastuzumab/pertuzumab and trastuzumab-emtansine sequence versus trastuzumab on overall survival.
ANNÉE2024
JOURNALCancers
PREMIER AUTEURCossu G
TITREUpdate on Neoadjuvant and Adjuvant BRAF Inhibitors in Papillary Craniopharyngioma: A Systematic Review.
ANNÉE2024
JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
PREMIER AUTEURAgnoux E
TITREReirradiation of bone metastasis: A narrative review of the literature.
ANNÉE2024
JOURNALEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
PREMIER AUTEURGoebel G
TITRESurgical patterns of care of pancreatic cancer. A French population-based study.
ANNÉE2024
JOURNALJHEP reports : innovation in hepatology
PREMIER AUTEURTaverniti V
TITRECAM-A-dependent HBV core aggregation induces apoptosis through ANXA1.
ANNÉE2024
JOURNALEuropean journal of cancer (Oxford, England : 1990)
PREMIER AUTEURM'Baloula J
TITREOlaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study.
ANNÉE2024
JOURNALJournal of medical virology
PREMIER AUTEURPrétet JL
TITREThe Sansure® Human Papillomavirus DNA Diagnostic Kit offers excellent reproducibility performance for the detection of high-risk HPV.
ANNÉE2024
JOURNALCell death discovery
PREMIER AUTEURDardare J
TITREDDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib.
ANNÉE2024
JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
PREMIER AUTEURCzuba E
TITREOvercoming the limits of pediatric brain tumor radiotherapy: The use of preclinical 3D models.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques